Raut, S. et al. 2023. UTILITY OF HBME1 IMMUNOSTAIN IN DIFFERENTIATING REACTIVE MESOTHELIAL CELLS LESIONS FROM MALIGNANT EPITHELIAL CELLS LESIONS IN SEROUS EFFUSIONS. Asian Journal of Pharmaceutical and Clinical Research. 16, 6 (Jun. 2023), 53–55. DOI:https://doi.org/10.22159/ajpcr.2023.v16i6.47279.